Angiotensin-(1-7) attenuates hypertension in exercise-trained renal hypertensive rats

Am J Physiol Heart Circ Physiol. 2012 Jun 1;302(11):H2372-80. doi: 10.1152/ajpheart.00846.2011. Epub 2012 Mar 30.

Abstract

Angiotensin-(1-7) [ANG-(1-7)] plays a counterregulatory role to angiotensin II in the renin-angiotensin system. In trained spontaneous hypertensive rats, Mas expression and protein are upregulated in ventricular tissue. Therefore, we examined the role of ANG-(1-7) on cardiac hemodynamics, cardiac functions, and cardiac remodeling in trained two-kidney one-clip hypertensive (2K1C) rats. For this purpose, rats were divided into sedentary and trained groups. Each group consists of sham and 2K1C rats with and without ANG-(1-7) infusion. Swimming training was performed for 1 h/day, 5 days/wk for 4 wk following 1 wk of swimming training for acclimatization. 2K1C rats showed moderate hypertension and left ventricular hypertrophy without changing left ventricular function. Chronic infusion of ANG-(1-7) attenuated hypertension and cardiac hypertrophy only in trained 2K1C rats but not in sedentary 2K1C rats. Chronic ANG-(1-7) treatment significantly attenuated increases in myocyte diameter and cardiac fibrosis induced by hypertension in only trained 2K1C rats. The Mas receptor, ANG II type 2 receptor protein, and endothelial nitric oxide synthase phosphorylation in ventricles were upregulated in trained 2K1C rats. In conclusion, chronic infusion of ANG-(1-7) attenuates hypertension in trained 2K1C rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin I / pharmacology
  • Angiotensin I / therapeutic use*
  • Animals
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Cardiotonic Agents / pharmacology
  • Cardiotonic Agents / therapeutic use*
  • Disease Models, Animal
  • Heart Ventricles / metabolism
  • Heart Ventricles / pathology
  • Heart Ventricles / physiopathology
  • Hypertension, Renal / physiopathology*
  • Hypertension, Renal / prevention & control*
  • Hypertrophy, Left Ventricular / pathology
  • Hypertrophy, Left Ventricular / prevention & control
  • Kidney / physiopathology
  • Kidney / surgery
  • Male
  • Nitric Oxide Synthase Type III / metabolism
  • Peptide Fragments / pharmacology
  • Peptide Fragments / therapeutic use*
  • Physical Conditioning, Animal / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 2 / metabolism
  • Surgical Instruments
  • Swimming / physiology*

Substances

  • Antihypertensive Agents
  • Cardiotonic Agents
  • Peptide Fragments
  • Receptor, Angiotensin, Type 2
  • Angiotensin I
  • Nitric Oxide Synthase Type III
  • angiotensin I (1-7)